Carve-in evidence continues to build

Linking pharmacy and medical benefits in one contract is better for the bottom line.

June 1, 2020
Pharmacy Benefit Carve-in Versus Carve-out: Cost and Medical Events Two-year Retrospective Cohort Study (Fall 2020)

Related news

Perspectives

January 24, 2023

Traditional Drug Pipeline Update: January 2023

This monthly pipeline wrap-up provides a review of newly approved traditional drugs, recent…

Perspectives

January 24, 2023

Specialty Pipeline Monthly Update: January 2023

This monthly pipeline wrap-up provides a review of newly approved specialty drugs, recent…

Perspectives

January 13, 2023

February 2023 decisions expected from the FDA

At Prime Therapeutics (Prime), we’ve positioned ourselves to best prepare our clients to…